Moreau, P <br/><br/>
A pilot study of 220 mg/m2 melphalan followed by autologous stem cell transplantation in patients with advanced haematological malignancies: pharmacokinetics and toxicity.  [electronic resource] 

 -  British journal of haematology  Dec 1996 
 - 527-30 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.1996.d01-1932.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Combined Modality Therapy<br/>Female<br/>Hematopoietic Stem Cell Transplantation--methods<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Melphalan--adverse effects<br/>Multiple Myeloma--drug therapy<br/>Pilot Projects<br/>Transplantation, Autologous